Biotechnology News

Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.

Dr Sandip Patel to Speak on Biomarkers for Cancer Immunotherapy: Beyond PD-L1

Dr Sandip Patel - Assistant Professor, Cancer Immunotherapy Program at UC San Diego Moores Cancer Centre will present at the Biomarker Conference to be held on 18–19 February 2016 in San Diego, USA. - November 22, 2015 - MarketsandMarkets

Altogen Biosystems In Vivo Pancreas Kit Has Applications for Diabetes Mellitus and Pancreatic Cancer

As featured by Science magazine, Altogen Biosystems offers a popular line of in vivo transfection reagent kits that include polymer, liposome, nanoparticle and PEG-liposome-based in vivo transfection kits as well as in vivo kits dedicated to targeting tissues, one of which is highlighted here: the... - November 21, 2015 - Altogen Biosystems

Two Research Reports Cite HemogloBind™ for Highly Efficient Sample Preparation

Biotech Support Group reports on two recent research reports which describe the simplicity and efficiency of their proteomic sample preparation technology for hemoglobin depletion. - November 20, 2015 - Biotech Support Group

BUHLMANN Laboratories Announces New, Direct US Affiliate

BUHLMANN Laboratories Announces New, Direct US Affiliate

BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015 - BUHLMANN Diagnostics Corp

Prosidyan Announces FDA 510(k) Clearance of FIBERGRAFT BG Morsels for Postero-Lateral Spinal Fusion

Prosidyan Announces FDA 510(k) Clearance of FIBERGRAFT BG Morsels for Postero-Lateral Spinal Fusion

NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT BG Morsels for Postero-lateral Spinal Fusion. FIBERGRAFT BG Morsels is an ultra-porous Bone Graft Substitute, made entirely... - November 16, 2015 - Prosidyan, Inc.

Global and USA Biosimilar Market: Updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim

SMi reports: (2015.11.06, Iselin, New Jersey, USA): Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November - November 08, 2015 - SAE Media Group

PMR: Global Compounding Pharmacies Market to Reach US$ 9.7 Bn by 2021

Asia Pacific is expected to emerge as the market portraying the healthiest growth rates throughout the forecast period. Certain markets in Asia Pacific such as Singapore are estimated to witness double-digit growth rates. - November 07, 2015 - Persistence Market Research

Zenalux Announces Grants from the National Institute of Health for Cancer Screening

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, has been awarded a grant from the National Institute of Health (NIH) to further develop the Zenascope® to screen for cancer by employing imaging and reducing operator error. Zenalux is also participating in an Academic Industry... - November 06, 2015 - Zenalux Biomedical, Inc.

Immanuel Pathways PACE Chooses CareKinesis for Its Pharmacy Services Provider

CareKinesis partners with health care organizations to provide personalized medication therapy management and pharmacy services for high-risk populations. The results are enhanced medication-related outcomes and greater operational efficiency. - October 22, 2015 - CareKinesis

Altogen Biosystems Develops Powerful In Vivo RNAi Research Tool for Oncology

Lipid-based liposomes of nanometer size are one of the most powerful molecules for delivery of novel therapeutics into target tissues enabling targeted cancer therapeutics. Pharma companies actively investigating new RNAi-based therapeutics where cargo molecules such as a small proteins, DNA,... - October 13, 2015 - Altogen Biosystems

The MCS Group, Inc. Launches New Website

The MCS Group, Inc. Launches New Website

The MCS Group, Inc., a national provider of outsourcing solutions, has launched a completely redesigned corporate website, providing a more engaging user experience with enhanced search and navigation as well as on-page forms, and a more user-friendly interface. - October 12, 2015 - The MCS Group, Inc.

Global 3D Cell Culture Market is Expected to Reach $2,750 Million by 2020

North America dominates the 3D cell culture market in the year 2015, followed by Europe and Asia. Asia is slated to witness the highest growth rate in the coming five years with China, Japan, Taiwan, India, Malaysia, and Singapore witnessing significant growth in the 3D cell culture market, as a result of their economic development, rising awareness regarding cancer in these countries, huge production of drugs in this region, and the growing focus of 3D cell culture players in these markets. - October 11, 2015 - Meticulous Research

Public Health of Castilla La Mancha Opts for the Legipid Rapid Test for Detecting Legionella in Water

The Public Health Laboratories of Castilla La Mancha (Spain) have introduced the Legipid® Legionella Fast Detection kit to determine Legionella in water. This kit was developed by the company Biotica Bioquimica Analitica (www.biotica.es), which belongs to the Science, Technology and Business Park of the Universitat Jaume I (Espaitec). - October 08, 2015 - Biotica Bioquimica Analitica

Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder

Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals

ELISA Biology Contract Research Services Provided by Altogen Labs

Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs

Regulate Gene Expression with Altogen Labs RNAi Technology

Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs

Baruch S. Blumberg Institute to Host 15th Annual Regional Biotech Conference

Conference at PA Biotech Center to focus on reducing costs of drug development. - October 03, 2015 - Hepatitis B Foundation

Novatein Biosciences Launches Cancer Biomarker ELISA Kits

Novatein Biosciences (www.novateinbio.com) is proud to add Cancer Biomarker ELISA Kits to its expanding product line. - October 03, 2015 - Novatein Biosciences

Voicebrook to Exhibit at THE Pathologists’ Meeting: CAP ‘15

Voicebrook to Exhibit at THE Pathologists’ Meeting: CAP ‘15

Company celebrates its 10th anniversary of participation at the annual College of American Pathologists event. - October 02, 2015 - Voicebrook, Inc.

Altogen Biosystems Releases Competitive In Vivo Polymer Kit

Altogen Biosystems has exclusively developed a highly effective In Vivo Polymer Transfection Kit that is capable of delivering siRNA, mRNA, small proteins, and DNA into various rodent tissues for pre-clinical and laboratory research. The efficacy of the Altogen Biosystems new in vivo transfection... - October 02, 2015 - Altogen Biosystems

New Generation of Tissue-Targeted Nanoparticle Based In Vivo Transfection Kit for Animal Research Developed by Altogen Biosystems

Researchers can now effectively deliver molecular targeted medicines into a myriad of tissues using nanotechnology. Altogen Biosystems has developed a new generation of highly efficient Nanoparticle-based In Vivo Transfection Kit that it exclusively manufactures. Nanoparticle technology can be... - October 02, 2015 - Altogen Biosystems

Pharma Cold Chain Experts Will Meet in London to Discuss Temperature-Controlled Distribution Strategy for Ambient Biologics Product and Reach to Emerging Markets

SMi Group Reports: Leading Pharma Cold Chain Distribution Experts from Genzyme, Pfizer, MHRA, World Courier, American Airlines and more will meet at the SMi Group’s 10th annual Cold Chain Distribution Conference - September 30, 2015 - SAE Media Group

FDA Renews Pinnacle 21 as Software Provider for DataFit

Pinnacle 21 announced today that it has been selected to provide custom software and related services to support the FDA’s DataFit program, which serves to expedite the new drug application process. - September 26, 2015 - Pinnacle 21

Xhale Submits Biomarker Qualification Package to FDA for Medication Adherence Monitoring Tool

Xhale, Inc. announced today that it has submitted to the Food and Drug Administration (FDA) the first Biomarker Qualification package for a Drug Development Tool for medication adherence monitoring. The submittal to FDA marks an important step for the company’s patented SMART® Medication... - September 25, 2015 - Xhale Inc

Marriage of Science and Marketing Makes Beautiful Skin Affordable

Marriage of Science and Marketing Makes Beautiful Skin Affordable

RxGenesys blends high-end stem cell tech with smart distribution and devoted customers to bring celebrity beauty secrets to real women -- on a budget. Less than three minutes and $1.50 a day visibly improve the skin’s appearance. When Sports Illustrated goddess Paulina Porizkova burst onto... - September 21, 2015 - RxGenesys

Voicebrook Selects St. Jude Children’s Research Hospital as 2015 #EmployeeConnect Charity Recipient

Voicebrook Selects St. Jude Children’s Research Hospital as 2015 #EmployeeConnect Charity Recipient

Company commits to raising money through support of charitable events - September 14, 2015 - Voicebrook, Inc.

Novatein Biosciences (NovaTeinBio.com) Launches Food ELISA Kits

Novatein Biosciences (www.novateinbio.com) continues to expand its product line with the launch of food ELISA kits. - September 12, 2015 - Novatein Biosciences

Houston Startup Noninvasix Earns Spot in Prominent Healthcare Startup Accelerator Program

Patient monitoring developer joins Health Wildcatters’ third startup class - September 10, 2015 - Noninvasix

NanoCellect and UCSD Team Up on Single-Cell Sorting and Analysis

NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life science researchers, begins a collaboration with UCSD to develop single cell applications based on their WOLF Cell Sorter. The WOLF Cell Sorter enables easy-to-use cell sorting that... - September 02, 2015 - NanoCellect

VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend

VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend

The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN

Oral Cancer Awareness Key to Survival

Oral Cancer Awareness Key to Survival

Scripps Oral Pathology Service (SOPS) offers CE course in Del Mar, CA, "Oral Pathology: From Differential Diagnosis to Biopsy." - August 26, 2015 - Scripps Oral Pathology Service

ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs

ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs

ALPCO has launched its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. - August 25, 2015 - ALPCO

Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit

Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations

Voicebrook to Sponsor at the Cortex User Group 2015

Voicebrook to Sponsor at the Cortex User Group 2015

Spotlight on Pathology Sciences Medical Group (PSMG) VoiceOver® integration - August 21, 2015 - Voicebrook, Inc.

CRO Analytics Appoints Bruce Wakeman as Chief Commercial Officer

CRO Analytics, the leading provider of clinical research quality performance indicators, announced today that Bruce M. Wakeman has joined the company as Chief Commercial Officer. Mr. Wakeman will be responsible for CRO Analytics’ overall commercial strategy and execution, and will implement... - August 20, 2015 - CRO Analytics

Concept Life Sciences Acquires CXR Biosciences to Augment Its Expanding Service Base in Discovery and PreClinical Sciences

Concept Life Sciences, scientific Laboratory and consultancy group has acquired CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life Sciences Group currently has over 600... - August 18, 2015 - Concept Life Sciences

NanoHybrids Launches Gold Nanoparticles Custom Designed to Improve Lateral Flow Quality and Reproducibility

Careful selection of indicator particles is absolutely critical to the performance of any lateral flow assay. NanoHybrids’ new line of monodisperse gold nanoparticles can enable the development of lateral flow assays that meet the highest specifications of the industry, particularly with respect to sensitivity and reproducibility. - August 16, 2015 - NanoHybrids

ABR Launches Bovine Polyomavirus Testing Service

ABR (now a VMRD division) announced today the availability of a new testing service that can detect the presence of bovine polyomavirus (BPyV) in animal origin products, master virus seeds, and other sample types. This infectivity assay, without using non-infectivity assays such as PCR, has the... - August 12, 2015 - VMRD, Inc.

Global Next Generation Sequencing (NGS) Market to Reach $8,599.5 Million by 2020

The Asian market, especially India and China, is expected to witness a boost in demand for NGS products and services and are poised to register maximum growth over the next five-six years, as a result of their economic development, increasing genetic research and development activities, drastically reduced mass scale genetic testing costs, and the growing focus of the global NGS players in this region. - August 07, 2015 - Meticulous Research

The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor

The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor

AmnioChor is a biotech startup engaged in perinatal stem cell technologies, founded with a long term vision and operating on a near term mandate. The vision is the ability to satisfy the therapeutic needs of Mesenchymal and Epithelial stem cells as the critical high volume foundation of new cures. The immediate mandate is to create the bank to serve that need through the cryopreservation of the living amniotic membrane of the placental sac. - August 06, 2015 - AmnioChor

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC

Fannin Innovation Studio and University of Houston Announce the Formation of GuidaBot, LLC

Technology enables interventions using real-time MRI guidance. - July 25, 2015 - Fannin Partners, LLC

MiTeGen Announces Mutual Distribution Agreements with Rigaku Reagents

MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with Rigaku Reagents. - July 23, 2015 - MiTeGen, LLC

NanoHybrids Enters into Distribution Agreement with Eikonix

NanoHybrids Inc, a biotechnology company based in Austin, Texas, and Eikonix, UK, a distributor of imaging systems and contrast agents announced today that they have entered into an agreement that adds NanoHybrids’ premium gold nanoparticles to Eikonix's extensive offering of scientific... - July 23, 2015 - NanoHybrids

PMR : Nanocellulose Market - Global Industry Analysis and Forecast 2015 - 2021

Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Nanocellulose Market: Global Industry Analysis and Forecast 2015 - 2021." - July 22, 2015 - Persistence Market Research

Compounding Pharmacies Market - Global Industry Size, Share, Trends Analysis 2015 - 2021, by Persistence Market Research

Persistence Market Research Pvt. Ltd has released a new forthcoming report on title "Compounding Pharmacies Market: Global Industry Analysis and Forecast 2015 - 2021." - July 22, 2015 - Persistence Market Research

Captiva Spine’s SmartLOX™ Cervical Plate System Receives Clearance for Enhanced and Patented Screw Locking Mechanism

Captiva Spine’s SmartLOX™ Cervical Plate System Receives Clearance for Enhanced and Patented Screw Locking Mechanism

Captiva Spine's SmartLOX™ Cervical Plate System has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) to market an enhanced cervical plate system with a patented screw locking mechanism. Their SmartLOX Cervical Plate System incorporates a proprietary Nitinol self-locking mechanism, which provides visual, audible, and tactile confirmation of the cervical screw locking. - July 21, 2015 - Captiva Spine, Inc

Medtown Ventures, LLC Announces Exclusive License Agreement with Georgia Tech Research Corporation

Medtown Ventures forms a new company, CellectCell Inc., to focus on commercialization of adhesive-signature based cell selection technology invented and patented by Georgia Tech. - July 17, 2015 - Medtown Ventures

Captiva Spine’s TowerLOX MIS Pedicle Screw System Receives Clearance for Enhanced Rod Insertion and Reduction

Captiva Spine’s TowerLOX MIS Pedicle Screw System Receives Clearance for Enhanced Rod Insertion and Reduction

Captiva Spine, Inc., a medical device organization dedicated to creating and maintaining sincere, honest, collaborative relationships to deliver smart, elegant, and intuitive spinal solutions, announced today it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) to... - July 08, 2015 - Captiva Spine, Inc

HPAPIs and Cytotoxic Drugs Manufacturing Market to Evolve Rapidly, Reports Roots Analysis

Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio. The report provides an extensive study of the contract manufacturing opportunity for this rapidly expanding market. It identifies various CMOs active in this space,... - July 04, 2015 - Roots Analysis

Press Releases 901 - 950 of 2,221